English | 简体中文 | 繁體中文 | 한국어
 Press Releases
Monday, September 24, 2018
Roche's investigational medicine entrectinib showed a durable response of more than two years in people with a specific type of lung cancer 15:50 ET
Roche's Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer 15:45 ET
VALLOUREC : Vallourec launches a new brand Vallourec.smart 14:32 ET
SpareBank 1 SMN : SpareBank 1 SMN changes mortgage rate 14:00 ET
Signify periodic share repurchase update 13:00 ET
KONE wins order to equip second phase of Finland's West Metro extension 12:00 ET
SFL - 2018 Annual General Meeting 11:25 ET
Prosafe SE: Equinor extends Safe Boreas at Mariner 10:59 ET
Valmet to supply new winding technology for Papier- u. Kartonfabrik Varel in Germany
10:00 ET
SpareBank 1 SMN : SpareBank 1 Gruppen and DNB to merge insurance Companies 08:45 ET
Invitation to a Q&A teleconference with Outotec 08:00 ET
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients 07:30 ET
Cargotec refines its strategy: focus on digitalisation and services continues, emphasis on customer centricity and productivity, financial targets remain unchanged 07:30 ET
Asiakastieto Group has now finalized the negotiations with employee representatives for the new organisation 07:01 ET
Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid 07:00 ET
Saturday, September 22, 2018
Medtronic Presents IN.PACT Global Study Three-Year Data and Total IN.PACT(TM) Imaging and Propensity Analyses 22:00 ET
Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES 19:41 ET
Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness 14:41 ET
New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD 14:36 ET
Friday, September 21, 2018
FRO - Changes to the Board composition 17:48 ET
GOGL - Changes to the Board composition 17:45 ET
ITCL - 2018 Annual General Meeting 17:37 ET
FRO - 2018 Annual General Meeting 16:48 ET
GOGL - 2018 Annual General Meeting 16:45 ET
Sandoz receives positive CHMP opinion for proposed biosimilar pegfilgrastim 13:27 ET
Novartis receives positive CHMP opinion for Gilenya® for the treatment of children and adolescents with MS, marking a major medical advance for young MS patients in Europe 13:25 ET
Novartis announces positive CHMP opinion for one-time gene therapy Luxturna® to treat children and adults with rare inherited retinal disease 13:24 ET
The arbitration proceedings between Valmet and Suzano Papel e Celulose S.A. have ended
12:00 ET
AMG Advanced Metallurgical Group N.V. Completes Multi-Year Agreement for 100% Renewable Energy Contract for UK Operations 07:00 ET
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: